Patients with myocardial infarction related potential malignant ventricular arrhythmia have high risk of sudden death. The aim of this clinical trial is evaluating therapeutic efficacy of unipolar or bipolar radiofrequency ablation in Coronary Artery Bypass Grafts (CABG) Surgery, which can reduce myocardial ischemia and block reentry circuits of ventricular arrhythmia at the same time. The observation indexes include the morbidity of potential malignant ventricular arrhythmia and major adverse cardiovascular events in mid-long-term after CABG surgery.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
180
Patients with myocardial infarction related potential malignant ventricular arrhythmia undergoing unipolar or bipolar radiofrequency ablation and Coronary Artery Bypass Grafts at the same time
Patients with myocardial infarction related potential malignant ventricular arrhythmia undergoing Coronary Artery Bypass Grafts
Xuanwu Hospital
Beijing, Beijing Municipality, China
RECRUITINGBeijing Chaoyang Hospital
Beijing, Beijing Municipality, China
RECRUITINGBeijing Anzhen Hospital
Beijing, Beijing Municipality, China
RECRUITINGMorbidity of potential malignant ventricular arrhythmia
The morbidity of potential malignant ventricular arrhythmia in 1 year after surgery
Time frame: 1 year after surgery
Morbidity of major adverse cardiovascular events
The morbidity of the major adverse cardiovascular events in 1 year after surgery
Time frame: 1 year after surgery
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.